Back
Apellis Pharmaceuticals, Inc. Vs. Vaxcyte, Inc. Industry Stock Comparison
Buy
57
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$25.21
Seasonality Move:
7.92%
Sell
33
PCVX
Vaxcyte, Inc.
Last Price:
$43.07
Seasonality Move:
-0.37%
Buy
57
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.20. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Vaxcyte, Inc. (PCVX)
is a Sell
Is Vaxcyte, Inc. a Buy, Sell or Hold?
-
The current Vaxcyte, Inc. [PCVX] share price is $43.06. The Score for PCVX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
PCVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $25.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
PCVX Stock Price Chart
What is Vaxcyte, Inc.'s stock price today?
-
The Vaxcyte, Inc. share price today is $43.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCVX is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 65.18 | Buy |
| Chaikin Money Flow: | -1901427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.86 - 24.06) | Buy |
| Bollinger Bands (100): | (21.09 - 27.03) | Buy |
PCVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.44 | Buy |
| Relative Strength Index (14 RSI): | 41.88 | Sell |
| Chaikin Money Flow: | -837439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.48 - 48.8) | Sell |
| Bollinger Bands (100): | (32.44 - 45.42) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.69 | Buy |
| 20-day SMA: | 22.45 | Buy |
| 50-day SMA: | 23.14 | Buy |
| 200-day SMA: | 21.91 | Buy |
| 8-day EMA: | 24.49 | Buy |
| 20-day EMA: | 23.28 | Buy |
| 50-day EMA: | 22.99 | Buy |
| 200-day EMA: | 24.27 | Buy |
PCVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.32 | Sell |
| 20-day SMA: | 46.39 | Sell |
| 50-day SMA: | 44.8 | Sell |
| 200-day SMA: | 39.72 | Buy |
| 8-day EMA: | 9.57 | Buy |
| 20-day EMA: | 4.1 | Buy |
| 50-day EMA: | 1.69 | Buy |
| 200-day EMA: | 0.43 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Vaxcyte, Inc. Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.39 per share, and a decrease next year of $0.91 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vaxcyte, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||